Literature DB >> 24998774

Characterization and osteogenic activity of a silicatein/biosilica-coated chitosan-graft-polycaprolactone.

Matthias Wiens1, Tarek A Elkhooly2, Heinz-Christoph Schröder2, Tawheed H A Mohamed3, Werner E G Müller2.   

Abstract

Several attempts have been made in the past to fabricate hybrid materials that display the complementary properties of the polyester polycaprolactone (PCL) and the polysaccharide chitosan (CHS) for application in the field of bone regeneration and tissue engineering. However, such composites generally have no osteogenic activity per se. Here we report the synthesis of a chitosan-graft-polycaprolactone (CHS-g-PCL) and its subsequent characterization, including crystallinity, chemical structure and thermal stability. Upon surface-functionalization of CHS-g-PCL with osteogenic biosilica via the surface-immobilized enzyme silicatein, protein adsorption, surface morphology and wettability were assessed. Finally, the cultivation of osteoblastic SaOS-2 cells on the surface-functionalized CHS-g-PCL was followed by analyses of cell viability, mineral deposition and alkaline phosphatase activity. These characterizations revealed a composite that combines the versatile properties of CHS-g-PCL with the osteogenic activity of the silicatein/biosilica coating and, hence, represents an innovative alternative to conventionally used CHS/PCL composites for biomedical applications, where stable bone-material interfaces are required.
Copyright © 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biosilica; Chitosan; Osteogenic activity; Polycaprolactone; Silicatein

Mesh:

Substances:

Year:  2014        PMID: 24998774     DOI: 10.1016/j.actbio.2014.06.036

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  7 in total

1.  Folic Acid-Doxorubicin-Double-Functionalized-Lipid-Core Nanocapsules: Synthesis, Chemical Structure Elucidation, and Cytotoxicity Evaluation on Ovarian (OVCAR-3) and Bladder (T24) Cancer Cell Lines.

Authors:  Rodrigo Cé; Vladimir Lavayen; Gabriela Klein Couto; João Guilherme Barreto De Marchi; Barbara Zoche Pacheco; Letícia Antunes Natividade; Tiago Ost Fracari; Taiane Medeiro Ciocheta; Aline de Cristo Soares Alves; Denise Soledade Jornada; Silvia Stanisçuaski Guterres; Fabiana Seixas; Tiago Collares; Adriana Raffin Pohlmann
Journal:  Pharm Res       Date:  2021-02-19       Impact factor: 4.200

2.  Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery.

Authors:  Andreia Almeida; Daniella Silva; Virginia Gonçalves; Bruno Sarmento
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

3.  Identifying N-terminal peptides by a combination of the edman procedures with a bromine isotope tag: Application to the silicateins.

Authors:  G A Fedorova; E S Korneva; A S Belikova; M A Grachev
Journal:  Protein Sci       Date:  2016-09-16       Impact factor: 6.725

4.  Biosilica from Living Diatoms: Investigations on Biocompatibility of Bare and Chemically Modified Thalassiosira weissflogii Silica Shells.

Authors:  Stefania Roberta Cicco; Danilo Vona; Roberto Gristina; Eloisa Sardella; Roberta Ragni; Marco Lo Presti; Gianluca Maria Farinola
Journal:  Bioengineering (Basel)       Date:  2016-12-16

5.  Biosynthetic PCL-graft-Collagen Bulk Material for Tissue Engineering Applications.

Authors:  Piergiorgio Gentile; Kegan McColgan-Bannon; Nicolò Ceretto Gianone; Farshid Sefat; Kenneth Dalgarno; Ana Marina Ferreira
Journal:  Materials (Basel)       Date:  2017-06-23       Impact factor: 3.623

Review 6.  Inorganic Polymeric Materials for Injured Tissue Repair: Biocatalytic Formation and Exploitation.

Authors:  Heinz C Schröder; Xiaohong Wang; Meik Neufurth; Shunfeng Wang; Rongwei Tan; Werner E G Müller
Journal:  Biomedicines       Date:  2022-03-11

7.  Minimally invasive implantation and decreased inflammation reduce osteoinduction of biomaterial.

Authors:  Zifan Zhao; Qin Zhao; Bin Gu; Chengcheng Yin; Kailun Shen; Hua Tang; Haibin Xia; Xiaoxin Zhang; Yanbing Zhao; Xiangliang Yang; Yufeng Zhang
Journal:  Theranostics       Date:  2020-02-18       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.